This suggests that WT and KO + VC mice recruit a large number of NKp46(+) cells and attenuate DSS-induced inflammation and mucus depletion through the production of a large amount of IL-22, whereas KO mice lack such factors to ameliorate the colitis caused by DSS treatment. This evidence concerns the gene IL22 and colitis.